RAD50 and cancer: The observed increased number and altered distribution of Rad50 foci suggest a gene defect that impairs the ability to repair IR-induced DSBs in cells from hypersensitive cancer patients, thus decreasing the DNA restoration rate in these cells compared to cells derived from healthy subjects and cancer patients with normal reaction to RT.